# A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function

> **NCT06340347** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Liver Diseases

## Interventions

- **DRUG:** Osivelotor

## Key facts

- **NCT ID:** NCT06340347
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-30
- **Primary completion:** 2024-09-18
- **Final completion:** 2024-09-18
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340347, "A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06340347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*